Skip to content
10-K

Annual Report

Janux Therapeutics, Inc. JANX

0001193125-26-076918

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 24, 2026 60.83M sh
Shares Diluted FY 2025 · Dec 31, 2025 61.97M sh
Shares Diluted FY 2025 · Dec 31, 2024 53.75M sh
Shares Diluted FY 2025 · Dec 31, 2023 44.02M sh
Capex FY 2025 · Dec 31, 2025 $1.04M
Capex FY 2025 · Dec 31, 2024 $359K
Capex FY 2025 · Dec 31, 2023 $1.85M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$82.24M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$43.81M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$50.58M
Short Term Investments FY 2025 · Dec 31, 2025 $914.23M
Short Term Investments FY 2025 · Dec 31, 2024 $594.57M
Cash And Equivalents FY 2025 · Dec 31, 2025 $52.33M
Cash And Equivalents FY 2025 · Dec 31, 2024 $430.61M
Stockholders Equity FY 2025 · Dec 31, 2025 $956.82M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.02B
Stockholders Equity FY 2025 · Dec 31, 2023 $344.35M
Stockholders Equity FY 2025 · Dec 31, 2022 $320.74M
Current Liabilities FY 2025 · Dec 31, 2025 $25M
Current Liabilities FY 2025 · Dec 31, 2024 $17.46M
Total Liabilities FY 2025 · Dec 31, 2025 $44.74M
Total Liabilities FY 2025 · Dec 31, 2024 $38.74M
Current Assets FY 2025 · Dec 31, 2025 $975.89M
Current Assets FY 2025 · Dec 31, 2024 $1.03B
Total Assets FY 2025 · Dec 31, 2025 $1B
Total Assets FY 2025 · Dec 31, 2024 $1.06B
Eps Diluted FY 2025 · Dec 31, 2025 −$1.83
Eps Diluted FY 2025 · Dec 31, 2024 −$1.28
Eps Diluted FY 2025 · Dec 31, 2023 −$1.32
Eps Basic FY 2025 · Dec 31, 2025 −$1.83
Eps Basic FY 2025 · Dec 31, 2024 −$1.28
Eps Basic FY 2025 · Dec 31, 2023 −$1.32
Sga Expense FY 2025 · Dec 31, 2025 $41.77M
Sga Expense FY 2025 · Dec 31, 2024 $41.05M
Sga Expense FY 2025 · Dec 31, 2023 $26.14M
Rd Expense FY 2025 · Dec 31, 2025 $125.9M
Rd Expense FY 2025 · Dec 31, 2024 $68.39M
Rd Expense FY 2025 · Dec 31, 2023 $54.92M
Net Income FY 2025 · Dec 31, 2025 −$113.63M
Net Income FY 2025 · Dec 31, 2024 −$68.99M
Net Income FY 2025 · Dec 31, 2023 −$58.29M
Operating Income FY 2025 · Dec 31, 2025 −$157.67M
Operating Income FY 2025 · Dec 31, 2024 −$98.85M
Operating Income FY 2025 · Dec 31, 2023 −$72.98M
Revenue FY 2025 · Dec 31, 2025 $10M
Revenue FY 2025 · Dec 31, 2024 $10.59M
Revenue FY 2025 · Dec 31, 2023 $8.08M